相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Phase II Clinical Trial of First or Second-Line Treatment with Bortezomib in Patients with Malignant Pleural Mesothelioma
Dean A. Fennell et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Proteasome Inhibitors Induce p53-Independent Apoptosis in Human Cancer Cells
Bulbul Pandit et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Estrogen-Mediated Upregulation of Noxa Is Associated with Cell Cycle Progression in Estrogen Receptor-Positive Breast Cancer Cells
Wensheng Liu et al.
PLOS ONE (2011)
Pseudomonas Exotoxin A-Mediated Apoptosis Is Bak Dependent and Preceded by the Degradation of Mcl-1
Xing Du et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
A randomized phase II study of bortezomib and pemetrexed, in combination or alone, in patients with previously treated advanced non-small-cell lung cancer
Giorgio V. Scagliotti et al.
LUNG CANCER (2010)
Role of ATF4 in regulation of autophagy and resistance to drugs and hypoxia
Tomasz Rzymski et al.
CELL CYCLE (2009)
Different mutants of PSMB5 confer varying bortezomib resistance in T lymphoblastic lymphoma/leukemia cells derived from the Jurkat cell line
Shuqing Lue et al.
EXPERIMENTAL HEMATOLOGY (2009)
Inhibition of DNA methyltransferase induces G2 cell cycle arrest and apoptosis in human colorectal cancer cells via inhibition of JAK2/STAT3/STAT5 signalling
Hua Xiong et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
ERAD inhibitors integrate ER stress with an epigenetic mechanism to activate BH3-only protein NOXA in cancer cells
Qiuyan Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Molecular basis of bortezomib resistance:: proteasome subunit β5 (PSMB5) gene mutation and overexpression of PSMB5 protein
Ruud Oerlemans et al.
BLOOD (2008)
Sensitivity of tumor cells to proteasome inhibitors is associated with expression levels and composition of proteasome subunits
Antonia Busse et al.
CANCER (2008)
Overexpression of the PSMB5 gene contributes to bortezomib resistance in T-lymphoblastic lymphoma/leukemia cells derived from Jurkat line
Shuqing Lue et al.
EXPERIMENTAL HEMATOLOGY (2008)
Point mutation of the proteasome β5 subunit gene is an important mechanism of bortezomib resistance in bortezomib-selected variants of Jurkat T cell lymphoblastic lymphoma/leukemia line
Shuqing Lu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Effect of bortezomib on human neuroblastoma: analysis of molecular mechanisms involved in cytotoxicity
Valerie Combaret et al.
MOLECULAR CANCER (2008)
Advances in the systemic therapy of malignant pleural mesothelioma
Dean A. Fennell et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2008)
Preclinical studies of the proteasome inhibitor bortezomib in malignant pleural mesothelioma
Gavin J. Gordon et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
BCL-2 family regulation by the 20S proteasome inhibitor bortezomib
D. A. Fennell et al.
ONCOGENE (2008)
Increased expression and altered subunit composition of proteasomes induced by continuous proteasome inhibition establish apoptosis resistance and hyperproliferation of Burkitt lymphoma cells
Dominik Fuchs et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Tumor cell-selective regulation of NOXA by c-MYC in response to proteasome inhibition
Mikhail A. Nikiforov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Molecular basis for estrogen receptor α deficiency in BRCA1-linked breast cancer
Alison M. Hosey et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
The proteasomal and apoptotic phenotype determine bortezomib sensitivity of non-small cell lung cancer cells
Jens Voortman et al.
MOLECULAR CANCER (2007)
Bortezomib inhibits nuclear factor-κB-dependent survival and has potent in vivo activity in mesothelioma
Andrea Sartore-Bianchi et al.
CLINICAL CANCER RESEARCH (2007)
SV40 oncoproteins enhance asbestos-induced DNA double-strand breaks and abrogate senescence in murine mesothelial cells
Jodie R. Pietruska et al.
CANCER RESEARCH (2007)
Randomized phase II study of bortezomib alone and bortezomib in combination with docetaxel in previously treated advanced non-small-cell lung cancer
Michael P. Fanucchi et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Expression of Bcl-2 family members in malignant pleural mesothelioma
Sara L. O'Kane et al.
ACTA ONCOLOGICA (2006)
Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: An intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada
JP van Meerbeeck et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Proteasome inhibitors trigger NOXA-mediated apoptosis in melanoma and myeloma cells
JZ Qin et al.
CANCER RESEARCH (2005)
Differential regulation of noxa in normal Melanocytes and melanoma cells by proteasome inhibition:: Therapeutic implications
Y Fernández et al.
CANCER RESEARCH (2005)
Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins
SN Willis et al.
GENES & DEVELOPMENT (2005)
Myc represses transcription through recruitment of DNA methyltransferase corepressor
C Brenner et al.
EMBO JOURNAL (2005)
Defective core-apoptosis signalling in diffuse malignant pleural mesothelioma: opportunities for effective drug development
DA Fennell et al.
LANCET ONCOLOGY (2004)
The proteasome inhibitor PS-341 overcomes TRAIL resistance in Bax and caspase 9-negative or Bcl-xL overexpressing cells
TR Johnson et al.
ONCOGENE (2003)
Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma
NJ Vogelzang et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Genomic targets of the human c-Myc protein
PC Fernandez et al.
GENES & DEVELOPMENT (2003)
BAX and BAK regulation of endoplasmic reticulum Ca2+:: A control point for apoptosis
L Scorrano et al.
SCIENCE (2003)
Nora, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis
E Oda et al.
SCIENCE (2000)
分享论文
